endralazine has been researched along with Blood Pressure, High in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogers, WA; Holmes, DG; Huunan-Seppala, A; Wideroe, B; Wideroe, TE | 1 |
| Bogers, WA; Meems, L | 2 |
| Gerber, W; Pally, C; Salzmann, R; Scholtysik, G | 1 |
| Reubi, FC; Wegmüller, E | 1 |
| Hoffmann, JJ; Thien, T; van T'Laar, A | 1 |
| Blaha, M; Dvorák, I; Dvorák, M; Havlát, F; Kubesová, H; Nĕmcová, H | 1 |
| Kilic, S | 1 |
| Fet'kovská, N; Tison, P | 1 |
| Rawat, R; Seedat, YK | 1 |
| Elliott, HL; Howden, CW; Lawrie, CB; Meredith, PA; Reid, JL | 1 |
| Elliott, HL; Meredith, PA; Reid, JL | 1 |
| Smits, JF; Struyker-Boudier, HA; van Essen, H | 1 |
| Izotov, AI; Postol'nikov, SF; Vygodin, VA | 1 |
| Donnelly, RJ; Elliott, HL; McLean, K; Reid, JL; Sumner, DJ | 1 |
| Elliott, HL; Kelman, AW; McSharry, DR; Meredith, PA; Reid, JL | 1 |
| Glöckner, WM; Kindler, J; Konrads, A; Meurer, KA; Schulz, V; Sieberth, HG; Vaith, P | 1 |
| Hochrein, H; Lehmann, HU; Meyer-Estorf, G | 1 |
| Hochrein, H; Lehmann, HU; Witt, E | 1 |
| Hartmann, HG; Schumacher, H | 1 |
| McGourty, JC; Pidgeon, J; Silas, JH | 1 |
| Chazan, BI; Duff, DA; McCallum, A; Whaley, K | 1 |
| Hauger-Klevene, JH; Mayer, E; Reader, C; Sanchez, MR | 1 |
| Izotov, AI; Malysheva, NV; Postol'nikov, SF | 1 |
| Carruthers, SG; Spence, JD; Wu, R | 1 |
| Kindler, J; Moedder, G; Sieberth, HG | 1 |
11 trial(s) available for endralazine and Blood Pressure, High
| Article | Year |
|---|---|
Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.
Topics: Acetylation; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Genes; Humans; Hydralazine; Hydrazones; Hypertension; Male; Pindolol; Pyridazines | 1983 |
[Experience with endralazine in the treatment of essential hypertension].
Topics: Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines | 1984 |
[Systolic hypertension. Treatment with endralazine].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines; Systole | 1983 |
[Endralazine in the treatment of hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines | 1984 |
A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Clopamide; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Pyridazines; Time Factors | 1984 |
[Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients].
Topics: Adult; Antihypertensive Agents; Cardiac Output; Cardiography, Impedance; Humans; Hydralazine; Hypertension; Kinetics; Middle Aged; Prazosin; Propranolol; Pyridazines; Vascular Resistance | 1984 |
[Management of treatment-resistant hypertension: comparison of the antihypertensive effect of endralazine and minoxidil (author's transl)].
Topics: Adolescent; Adult; Aged; Female; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged; Minoxidil; Pyridazines; Pyrimidines; Sleep Wake Disorders | 1981 |
Comparison of once daily endralazine with placebo in the treatment of hypertension uncontrolled by a beta-blocker and diuretic.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Posture; Pyridazines; Random Allocation; Time Factors | 1985 |
Comparative study of endralazine and hydralazine for the treatment of hypertension uncontrolled by a beta-blocker and diuretic.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antibodies, Antinuclear; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Pyridazines; Random Allocation | 1986 |
A comparative study of endralazine and captopril in essential hypertension: effect on renin levels, pulmonary function studies and lipid profile.
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Drug Evaluation; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Pyridazines; Random Allocation; Renin; Respiratory Function Tests | 1986 |
[Endralazine monotherapy in comparison with prazosin and hydralazine in arterial hypertension].
Topics: Adult; Clinical Trials as Topic; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Pyridazines | 1986 |
15 other study(ies) available for endralazine and Blood Pressure, High
| Article | Year |
|---|---|
Endralazine and acetylator phenotype.
Topics: Acetylation; Antihypertensive Agents; Humans; Hypertension; Phenotype; Pyridazines | 1983 |
Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Drug Therapy, Combination; Guanfacine; Guanidines; Heart Rate; Hypertension; Male; Phenylacetates; Pyridazines; Rats; Rats, Inbred Strains; Vasodilator Agents | 1983 |
Changes in renal function induced by endralazine, a new antihypertensive drug.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Natriuresis; Potassium; Pyridazines; Renal Circulation; Renin; Urea | 1983 |
Effects of intravenous endralazine in essential hypertension.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pyridazines; Renin; Time Factors | 1983 |
Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives.
Topics: Adult; Blood Pressure; Heart Rate; Humans; Hypertension; Kinetics; Male; Pyridazines; Vasodilator Agents | 1984 |
Pharmacodynamic and pharmacokinetic studies with the vasodilator endralazine.
Topics: Adult; Blood Pressure; Drug Evaluation; Humans; Hypertension; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Pyridazines; Random Allocation; Time Factors; Vasodilator Agents | 1984 |
Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat.
Topics: Animals; Denervation; Dihydralazine; Hemodynamics; Hydralazine; Hypertension; Male; Pressoreceptors; Pyridazines; Rats; Vasodilator Agents | 1983 |
Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pyridazines; Renin; Vasodilator Agents | 1982 |
Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.
Topics: Acetylation; Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Phenotype; Pindolol; Pyridazines; Time Factors; Vasodilator Agents | 1983 |
The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects.
Topics: Acetylation; Administration, Oral; Aged; Antihypertensive Agents; Female; Humans; Hypertension; Injections, Intravenous; Kinetics; Male; Middle Aged; Pyridazines | 1983 |
[Clinical effectiveness of BQ 22-708, a pyridopyridazine derivative, in the treatment of fixed essential hypertension].
Topics: Drug Evaluation; Female; Heart Rate; Humans; Hypertension; Male; Pyridazines | 1978 |
[Evaluation of a pyridopyridazine as a drug with marked antihypertensive properties (author's transl)].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Capillaries; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pulmonary Artery; Pyridazines; Vascular Resistance | 1977 |
[Antihypertensive pharmacotherapy with the vasodilators captopril and endralazine].
Topics: Adrenergic beta-Antagonists; Adult; Captopril; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Proline; Pyridazines; Vasodilator Agents | 1985 |
Evaluation of once daily endralazine in hypertension.
Topics: Acetylation; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines | 1986 |
Tissue distribution of endralazine and its clinical effect in refractory hypertension.
Topics: Animals; Antihypertensive Agents; Autoradiography; Blood Pressure; Carbon Radioisotopes; Clonidine; Female; Humans; Hypertension; Hypertension, Renal; Male; Mice; Pregnancy; Prospective Studies; Pyridazines; Tissue Distribution | 1985 |